These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35522029)

  • 1. Pharmacist-Led Deprescribing for Patients With Polypharmacy and Chronic Disease States: A Retrospective Cohort Study.
    Chan M; Plakogiannis R; Stefanidis A; Chen M; Saraon T
    J Pharm Pract; 2023 Oct; 36(5):1192-1200. PubMed ID: 35522029
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
    Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
    Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
    Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
    Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.
    Green AR; Quiles R; Daddato AE; Merrey J; Weffald L; Gleason K; Xue QL; Swarthout M; Feeser S; Boyd CM; Wolff JL; Blinka MD; Libby AM; Boxer RS
    J Am Geriatr Soc; 2024 Jul; 72(7):1973-1984. PubMed ID: 38488757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprint of: Pharmacist-driven deprescribing initiative in primary care.
    Rea E; Portman D; Ioannou K; Lumley B
    J Am Pharm Assoc (2003); 2024; 64(4S):102162. PubMed ID: 39127936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
    Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
    Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System.
    Rashid R; Chang C; Niu F; Deguzman L; Draves M; Awsare S; Hui R
    J Manag Care Spec Pharm; 2020 Jul; 26(7):918-924. PubMed ID: 32584681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
    Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
    Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-driven deprescribing initiative in primary care.
    Rea E; Portman D; Ioannou K; Lumley B
    J Am Pharm Assoc (2003); 2024; 64(1):139-145. PubMed ID: 37722503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.
    Ó Ciardha D; Blake AM; Creane D; Callaghan MÓ; Darker C
    BMJ Open; 2022 May; 12(5):e050261. PubMed ID: 35623753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials.
    Dills H; Shah K; Messinger-Rapport B; Bradford K; Syed Q
    J Am Med Dir Assoc; 2018 Nov; 19(11):923-935.e2. PubMed ID: 30108032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Pharmacist-Driven Aspirin Deprescribing Protocol Among Older Veterans in a Primary Care Setting.
    Varghese CJ; Grunske M; Nagy MW
    Sr Care Pharm; 2024 Jun; 39(6):228-234. PubMed ID: 38803026
    [No Abstract]   [Full Text] [Related]  

  • 19. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): A feasibility study.
    Cross AJ; George J; Woodward MC; Le VJ; Elliott RA
    Res Social Adm Pharm; 2020 Oct; 16(10):1392-1397. PubMed ID: 32014358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.